Table: Shin Nippon Biomedical - 9-MTH group results
Feb 8 (Reuters)-
Shin Nippon Biomedical Laboratories Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 12.23 11.50 15.39
(+6.4 pct) (-0.5 pct) (-7.3 pct)
Operating 341 mln loss 1.18 388 mln
Recurring 1.02 loss 921 mln 489 mln
Net 1.57 loss 1.94 816 mln
EPS 37.60 yen loss 46.63 yen 19.60 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Shin Nippon Biomedical Laboratories Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T